Project description
Innovative imaging platform for effective removal of cancerous tissue
Effective removal of cancerous tissue by endoscopic surgery is challenging, partially because of the difficulty of differentiation of tissue types with current imaging technologies. Thericon in Germany is developing a real-time multispectral imaging platform with multiparametric images to assist in the effective removal of cancerous tissue and the reduction of cancer recurrence in patients. The company has developed a prototype device and completed initial validation in bladder cancer applications. The EU-funded rMSI project aims to complete clinical application studies, safety tests and certification of the final product in preparation for marketing.
Objective
Cancer is the leading cause of death in the EU, with 2.7M diagnoses and 1.3M deaths in 2020. Effective removal of cancerous tissue through endoscopic surgery is challenging because of limited visual and absent tactile information, along the limitations of current imaging technologies, which make it difficult for surgeons to differentiate between different types of tissue. For this market, Thericon is developing an rMSI (real-time multispectral imaging) platform providing surgeons with multi-parametric images that help with effective removal of cancerous tissue and reduction of cancer recurrence in patients. The company has developed a prototype for its first product, named rMSI 2, and completed initial validation for bladder cancer applications. Thericon is asking for a 2.5M EIC grant and 5.5M equity funding to complete clinical application pilots, safety tests and CE certification for this product, getting it ready for market launch in 2024.
Fields of science
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
Keywords
Programme(s)
- HORIZON.3.1 - The European Innovation Council (EIC) Main Programme
Funding Scheme
HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended FinanceCoordinator
68167 Mannheim
Germany
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.